Killer Mike escorted out of Grammys in handcuffs after winning 3 awards

2024-12-25 10:12:34 source:is lotradecoin safe for beginners category:Scams

Killer Mike's triumphant run at the 2024 Grammys has taken a turn after the rapper was handcuffed Sunday at music's biggest night.

Killer Mike — who won three awards during the pre-show ceremony — was escorted out of the Crypto.com arena in handcuffs by a squad of police officers following his big win, video shared by The Hollywood Reporter's Chris Gardner on X shows.

It's unclear if the rapper was arrested or will return for the live ceremony.

USA TODAY has reached out to reps for Killer Mike, the Recording Academy and the Los Angeles Police Department.

Killer Mike won Grammys for best rap song and best rap performance for his song "Scientists and Engineers" and best rap album for "Michael."

Cradling his trio of awards after sweeping his nominated rap categories, Killer Mike gave a motivational speech to reporters backstage.

"Keep running your race. If you think you think you can jump 20 feet, jump 40," he said. "It is our responsibility to be grand at everything. … The only thing that limits you is you. The only thing that limits your age is not being truthful about your age."

He added: "At 20, I thought it was cool to be a drug dealer (and) at 48, I stand here a man of sympathy and empathy for the things I’ve done."

Killer Mike last won a Grammy in 2003 for best rap performance by a duo or group for his feature on OutKast's "The Whole World."

Contributing: Melissa Ruggieri

More:Scams

Recommend

Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Follow Your Dreams

There are spoilers ahead. You might want to solve today's puzzle before reading further! Follow Your

Lawyer says Epstein plea deal protects Ghislaine Maxwell, asks judge to ditch conviction

A lawyer for Ghislaine Maxwell, the socialite serving a 20-year prison sentence for luring young gir

Eli Lilly teams with Amazon to offer home delivery of its Zepbound weight-loss drug

Four months after Eli Lilly obtained regulatory approval to sell its diabetes medication under a dif